Results 71 to 80 of about 19,682 (247)
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner +6 more
wiley +1 more source
AIM2 as a putative target in acute kidney graft rejection
Acute rejection (AR) is a process triggered via the recognition of grafted organ-derived antigens by the immune system, which could present as a life-threatening condition. In the context of a kidney transplant, despite improvement with immunosuppressive therapies, AR maintains a significant incidence of 10%, and currently available drugs generally act
Nathália Franchon Marques Tejada +7 more
openaire +3 more sources
Inflammatory caspases : key regulators of inflammation and cell death [PDF]
The innate immune system represents the first line of defence against infectious agents, and co-ordinates cellular and molecular mechanisms that result in effective inflammatory and anti-microbial responses against pathogens.
Jiménez Fernandez, Daniel +1 more
core +2 more sources
HIFU‐Driven Targeted Pyroptosis Therapy in Basal‐Like Breast Cancer
This study presents a HIFU‐driven pyroptosis strategy for BLBC treatment. Combining HIFU with platelet‐membrane hybridized liposomes encapsulating mitoxantrone enhances tumor targeting and efficacy. The synergistic treatment modulates key epigenetic regulators and activates the pyroptotic pathway through ROS generation and inflammasome signaling ...
Xiaomin Su +13 more
wiley +1 more source
The role of AIM2 in inflammation and tumors
Absent in melanoma 2 (AIM2) serves as an intracellular nucleic acid sensor that predominantly detects double-stranded DNA (dsDNA) within the cells. This detection initiates the assembly of inflammasome and activates the inflammasome signaling cascade, resulting in the production of inflammatory mediators and the cleavage of Gasdermins.
Dalang Yu +8 more
openaire +3 more sources
Structure of the Absent in Melanoma 2 (AIM2) Pyrin Domain Provides Insights into the Mechanisms of AIM2 Autoinhibition and Inflammasome Assembly [PDF]
AIM2 binds dsDNA and associates with ASC through their PYDs to form an inflammasome.The AIM2 PYD structure illustrates distinct charge distribution and a unique hydrophobic patch.The AIM2 PYD may bind the ASC PYD and the AIM2 HIN domain through overlapping surface.These findings provide insights into the mechanisms of AIM2 autoinhibition and ...
Jiansheng Jiang +4 more
openaire +3 more sources
AIM2-inflammasome role in systemic lupus erythematous and rheumatoid arthritis
The inflammasome AIM2 regulates multiple aspects of innate immune functions and serves as a critical mediator of inflammatory responses. AIM2 inflammasome activation leads to the production of pro-inflammatory cytokines, IL-1β and IL-18 and participates ...
E. E. Uresti-Rivera +1 more
doaj +1 more source
Molecular Alterations and Association with Clinical Parameters [PDF]
Lynch syndrome is caused by germline mutations of DNA mismatch repair (MMR) genes, most frequently MLH1 and MSH2. Recently, MMR-deficient crypt foci (MMR- DCF) have been identified as a novel lesion which occurs at high frequency in the intestinal mucosa
Benner, Axel +11 more
core +1 more source
GSK461364 Inhibits NLRP3 Inflammasome by Targeting NEK7 Phosphorylation
Schematic diagram of the mechanism by which GSK461364 inhibits NLRP3 inflammasome activation. GSK461364 inhibits the phosphorylation of NEK7 likely at serine 221 and serine 260 by suppressing the activity of PLK1, thereby restraining the formation of the NLRP3 inflammasome.
Ruiheng Luo +13 more
wiley +1 more source
Lipopolysaccharide induces upregulation of the magnesium (Mg2+) efflux transporter solute carrier family 41 member 1 in dental stem cells, leading to a decrease in intracellular Mg2+ concentration and promoting the binding of oligomycin sensitivity‐conferring protein and cyclophilinD.
Yuan Liu +11 more
wiley +1 more source

